Preclinical data on Caliway&#39;s fat reduction drug candidate CBL-514 in combination with GLP-1R-based weight-loss therapies has been selected for oral presentation at the European Congress on Obesity (ECO 2026)

CBL-514 - Caliway Biopharmaceuticals

Mar 19, 2026